FDA Adverse Event Malfunction Summary report: N

ID CORE XT

MDR report key: 12096982 · Received June 30, 2021

Report

Report Number
3006413195-2021-00005
Event Type
Malfunction
Date Received
June 30, 2021
Date of Event
April 22, 2021
Report Date
July 27, 2021
Manufacturer
PROGENIKA BIOPHARMA, S.A
Product Code
PEP
UDI-DI
08437013457064
PMA / PMN Number
BP170154
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
IT
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THE FALSE POSITIVE RESULT OBTAINED BY ID CORE XT IS NOT CONSIDERED A DISCREPANT RESULT OR MALFUNCTION. THERE IS A DEVIATION FROM THE PACKAGE INSERT INSTRUCTIONS REGARDING SAMPLE QUALITY. THE CUSTOMER IS REQUESTED TO EXTRACT AND ANALYZE A NEW SAMPLE THAT MEETS THE QUALITY REQUIREMENTS OF THE PACKAGE INSERT.

Additional Manufacturer Narrative · 1

THE INVESTIGATION IS STILL ON-GOING. NO CONCLUSION IS AVAILABLE FOR THIS MALFUNCTION.

Description of Event or Problem · 1

THE CUSTOMER REPORTED A POSSIBLE DISCREPANCY. THE SEROLOGICAL PHENOTYPE WAS E- BUT WHEN TESTED WITH ID CORE XT RESULTED PHENOTYPE WAS E+.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
989783 ID CORE XT ID CORE XT PEP PROGENIKA BIOPHARMA, S.A 1020220034 0203000023 08437013457064

Patients

Seq Age Sex Outcome Treatment
1